Fungal Species: Ganoderma lucidum (Lingzhi)

Leveraging polysaccharide-derived nanocarriers to open new horizons in oral vaccine activation

mycolabadmin

Oral vaccines are easier to administer than injections, but the stomach’s harsh environment destroys them before they work. Scientists are developing special nanocarrier particles made from natural plant materials, especially those used in traditional Chinese medicine, that protect vaccine ingredients and trigger stronger immune responses in the gut. These carriers work like protective vehicles that deliver vaccines safely to immune cells in the intestines, potentially revolutionizing how we vaccinate people worldwide.

Read More »

Recent Advances in the Use of Ganoderma lucidum and Coriolus versicolor Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer

mycolabadmin

This review explores how two medicinal mushrooms traditionally used in Asian medicine—Lingzhi and Yunzhi—can enhance the effectiveness of lung cancer drugs (EGFR-TKIs) and help overcome drug resistance. These mushrooms contain special compounds that can fight cancer in multiple ways, boost the immune system, and reduce side effects. The research suggests that combining these mushrooms with standard cancer treatments may improve outcomes for lung cancer patients.

Read More »

Synergistic target network construction and dynamic simulation analysis based on a prospective systems pharmacology strategy

mycolabadmin

Researchers used computer-based methods to study how Sang Huang, a traditional medicinal fungus, might help treat type 2 diabetes. They identified 17 active compounds in the fungus and found that a key component called estradiol dipropionate could improve insulin sensitivity and glucose control by activating specific protein pathways. The study suggests Sang Huang could be a promising natural treatment for diabetes, though more laboratory and animal testing is needed.

Read More »

Promoting rational herb-drug use through pharmacy-led advice and home visits in NCD patients

mycolabadmin

This study showed that when pharmacists visited NCD patients at home and provided education about the risks of combining herbal products with prescribed medications, patients significantly improved their knowledge and safe usage behaviors. The intervention successfully reduced the number of patients at risk of harmful herb-drug interactions from 37.5% to 25%. The findings suggest that simple home-based pharmacist counseling can be an effective way to help chronic disease patients safely use both herbs and medications together.

Read More »
Scroll to Top